Universal Health (UHS)
NYSE:UHS
Want to see UHS full AI Analyst Report?
UHS Stock Chart & Stats
$182.41
$2.61(1.40%)
At close: 4:00 PM EST
$182.41
$2.61(1.40%)
Day’s Range― - ―
52-Week Range$152.33 - $246.33
Previous CloseN/A
Volume143.67K
Average Volume (3M)679.57K
Market Cap
$11.00B
Enterprise Value$16.97B
Total Cash (Recent Filing)$137.80M
Total Debt (Recent Filing)$5.51B
Price to Earnings (P/E)9.3
Beta0.60
Next Earnings
Apr 27, 2026EPS Estimate
5.44Next Dividend Ex-DateN/A
Dividend Yield0.35%
Share Statistics
EPS (TTM)5.88
Shares Outstanding53,837,856
10 Day Avg. Volume475,773
30 Day Avg. Volume679,565
Financial Highlights & Ratios
PEG Ratio0.26
Price to Book (P/B)1.91
Price to Sales (P/S)0.80
P/FCF Ratio16.32
Enterprise Value/Market Cap1.54
Enterprise Value/Revenue0.98
Enterprise Value/Gross Profit1.08
Enterprise Value/Ebitda6.19
Forecast
1Y Price Target
$242.00Price Target Upside32.67% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
EPS Forecast (FY)23.49
Revenue Forecast (FY)$18.48B
Bulls Say, Bears Say
Bulls Say
Acquisition And Virtual CareTalkspace acquisition is expected to be slightly accretive to adjusted earnings and enables a virtual intensive outpatient offering that can capture more post-discharge patients and expand the company's care continuum.
Behavioral Health StabilizationBehavioral-health patient days and admissions showed modest growth while staffing conditions improved, indicating potential stabilization and gradual recovery in that segment.
Capital Allocation And GuidanceManagement's profit guidance appears stronger than peers and share repurchases are expected to remain an active capital-allocation tool alongside the acquisition, supporting near-term shareholder returns.
Bears Say
Balance-sheet LeverageAcquisition financing increases financial leverage, which may constrain balance-sheet flexibility and limit the company's ability to pursue other strategic initiatives.
Payor Denials And Revenue RiskElevated payor denials are reducing revenue growth and introduce downside risk to revenue trends if denial rates do not improve.
Policy And Staffing HeadwindsExpiration of government subsidies combined with potential state behavioral-staffing requirements could reduce insured patient volumes and raise operating costs, creating meaningful headwinds for acute and behavioral results.
Universal Health News
UHS FAQ
What was Universal Health’s price range in the past 12 months?
Universal Health lowest stock price was $152.33 and its highest was $246.32 in the past 12 months.
What is Universal Health’s market cap?
Universal Health’s market cap is $11.00B.
When is Universal Health’s upcoming earnings report date?
Universal Health’s upcoming earnings report date is Apr 27, 2026 which is in 8 days.
How were Universal Health’s earnings last quarter?
Universal Health released its earnings results on Feb 25, 2026. The company reported $5.88 earnings per share for the quarter, beating the consensus estimate of $5.86 by $0.02.
Is Universal Health overvalued?
According to Wall Street analysts Universal Health’s price is currently Undervalued.
Does Universal Health pay dividends?
Universal Health pays a Quarterly dividend of $0.2 which represents an annual dividend yield of 0.35%. See more information on Universal Health dividends here
What is Universal Health’s EPS estimate?
Universal Health’s EPS estimate is 5.44.
How many shares outstanding does Universal Health have?
Universal Health has 53,837,856 shares outstanding.
What happened to Universal Health’s price movement after its last earnings report?
Universal Health reported an EPS of $5.88 in its last earnings report, beating expectations of $5.86. Following the earnings report the stock price went down -11.442%.
Which hedge fund is a major shareholder of Universal Health?
Currently, no hedge funds are holding shares in UHS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Universal Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$242.00 (32.67% Upside)
$242.00 (32.67% Upside)
Blogger Sentiment
Neutral
UHS Sentiment 57%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 237.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $128.1K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days <0.1%
Last 30 Days ▲ 5.6%
Last 30 Days ▲ 5.6%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
4.76%
12-Months-Change
Fundamentals
Return on Equity
21.03%
Trailing 12-Months
Asset Growth
7.43%
Trailing 12-Months
Company Description
Universal Health
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. The company operates through Acute Care Hospital Services and Behavioral Health Care Services segments. Its hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services. As of February 24, 2022, it owned and/or operated 363 inpatient facilities, and 40 outpatient and other facilities located in 39 states; Washington, D.C.; the United Kingdom; and Puerto Rico. The company also provides commercial health insurance services; and various management services, which include central purchasing, information, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. founded in 1978 and is headquartered in King of Prussia, Pennsylvania.
UHS Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call balanced strong operating and financial results — double-digit revenue and EPS growth, improved acute margins, a clear growth pipeline (inpatient expansions and outpatient behavioral rollout), active buybacks and accelerated AI adoption — against several manageable but material near-term risks including a $75M exchange-related headwind, a ~$35M one-time 2026 impact from California staffing rules (with ~$30M ongoing), timing-driven cash flow/AR pressure and localized market softness. Management provided constructive 2026 guidance that incorporates these headwinds while signaling confidence in margin expansion, volume recovery and technology-enabled efficiency gains.View all UHS earnings summariesUHS Net revenue Breakdown
9.61% Medicare
10.85% Managed Medicare
12.97% Medicaid
13.27% Managed Medicaid
25.89% Managed Care (HMO and PPOs)
5.07% UK Revenue
6.41% Other patient revenue and adjustments, net
7.08% Other non-patient revenue
UHS Stock 12 Month Forecast
Average Price Target
$242.00
▲(32.67% Upside)
Technical Analysis
Ownership Overview
5.93% Insiders
30.70% Mutual Funds
0.28% Other Institutional Investors
32.51% Public Companies and
Individual Investors